For the last three years, Yale SOM's Rodrigo Canales has led a project studying police forces in Mexico and testing approaches to building more effective and trusted departments.
In the developing world, many of those most at risk from the economic effects of COVID-19 are beyond the reach of aid programs. Yale SOM’s Kevin Donovan is testing the use of the transfers in a slum on the outskirts of Nairobi.
Around the United States, states are easing the restrictions imposed to slow the spread of COVID-19. We asked Yale SOM’s Dr. Howard Forman if these moves are premature and what is needed for Americans to return to school and work safely.
Since health insurance is tied to employment in the United States, Americans are losing their insurance just as they need it most. We asked economist Fiona Scott Morton, an expert on the healthcare industry, what a better system would look like.
We asked Yale SOM’s Robert Shiller, whose latest book is 'Narrative Economics,' to tell us what collective stories are forming around the pandemic and what they might mean for our economic future.
We asked Cristina Rodríguez of Yale Law School, whose research interests include immigration law and policy, to explain the consequences of President Donald Trump's April 22 proclamation on immigration during the COVID-19 crisis.
The COVID-19 crisis has intensified the debate over big data and privacy. Governments are pulling together data from public and private systems in order to predict and counter the spread of COVID-19. But setting aside privacy protections in a time of crisis could lead to new, permanent norms.
A team of Yale researchers says we should all be wearing cloth masks, but give the surgical masks to healthcare workers.
Companies often purchase competitors, not to acquire their ideas and products, but to shut them down. A recent report raised questions about whether such an acquisition may be partially responsible for a shortage of ventilators in the United States.
As pharmaceutical companies work to develop potential vaccines and treatments for COVID-19, they are operating under extreme pressure—as well as the restrictions on movement and interaction that are affecting all of us.